HomeCALTX • STO
add
Calliditas Therapeutics AB
Previous close
kr 106.60
Day range
kr 106.70 - kr 111.50
Year range
kr 80.80 - kr 141.90
Market cap
6.35B SEK
Avg Volume
141.62K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 451.56M | 5.25% |
Operating expense | 405.03M | 6.16% |
Net income | -18.37M | -398.99% |
Net profit margin | -4.07 | -373.26% |
Earnings per share | -0.34 | -2,424.13% |
EBITDA | 25.29M | -37.01% |
Effective tax rate | -28.84% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 973.73M | -22.04% |
Total assets | 1.86B | -4.80% |
Total liabilities | 1.52B | 28.46% |
Total equity | 334.81M | — |
Shares outstanding | 53.67M | — |
Price to book | 17.08 | — |
Return on assets | 3.49% | — |
Return on capital | 4.97% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -18.37M | -398.99% |
Cash from operations | 22.84M | -90.07% |
Cash from investing | -2.35M | -60.57% |
Cash from financing | 208.52M | -26.22% |
Net change in cash | 186.85M | -63.57% |
Free cash flow | 40.86M | -80.92% |
About
Founded
2004
Website
Employees
217
